Can a targeted nerve block spare children from opioids after chest surgery?

NCT ID NCT07796399

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 01, 2026 · Last updated Sep 02, 2026 · Updated 1 time

Summary

This trial tests two nerve block techniques to see which one better relieves shoulder pain in children after chest surgery. Researchers will compare pain scores, opioid use, and complication rates between the two blocks. The goal is to find a safer, more effective way to manage pain and reduce opioid side effects in young patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Two regional anesthesia techniques: an interscalene brachial plexus block and an anterior supraclavicular nerve block, both given during thoracic surgery to manage postoperative shoulder pain.
What this could lead to
If one block works better, it could become the standard for easing shoulder pain after chest surgery in children, reducing the need for opioids and their side effects.
What could go wrong
This is a mid-stage trial with 126 participants, so results may not apply to all children. Nerve blocks carry risks like infection, bleeding, or nerve damage, though these are uncommon.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 126 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2026

Expected to finish

Apr 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ASA physical status II-III * Elective open thoracotomy Exclusion Criteria: * Pre-existing shoulder pathology * Coagulopathy or infection at injection site * Allergy to local anesthetics * Neurological disorders involving upper limb

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nerve block/methods are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Cancer Hospital 57357

    RECRUITING

    Cairo, Egypt, 11617, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.